Natco Pharma Buyback 2023 Latest News Today

February 26, 2024 5:15:00 AM

2/- (Rupees two only) each for the financial year 2023-24," the company said in an exchange filing. Natco Pharma Limited Dividend 2024 Record date According to an exchange filing, Natco Pharma ...

March 27, 2024 2:54:00 PM

Geojit is bullish on NATCO Pharma has recommended buy rating on the stock with a target price of Rs 765 in its research report dated June 21, 2023. The US Food and Drug Administration (USFDA ...

April 13, 2024 5:09:00 AM

Fresenius, a German pharmaceutical company, and Fresenius Kabi Deutschland sued Natco Pharma USA on April 12 in Delaware District Court over patent infringement claims. The court action ...

April 9, 2024 7:53:00 AM

Natco Pharma Ltd, a leading Indian pharmaceutical ... inspection conducted by the USFDA at the facility in October 2023. The Kothur facility produces various pharmaceutical products for the ...

April 10, 2024 1:28:00 PM

FDA slams Eugia with Form 483 and posts older reprimands for AGC, Baxter The regulatory rebuke follows an inspection of Kilitch�s facility in Navi Mumbai from Oct. 12 to Oct. 20, 2023.

February 16, 2024 11:25:00 AM

Natco Pharma Ltd has reported over three-fold increase in consolidated net profit, reaching Rs 212.7 crore in the third quarter ending on December 31, 2023, propelled by robust revenue growth.

February 26, 2024 7:41:00 PM

Natco Pharma Share Price Today : Natco Pharma's stock opened at ?1008.95 and closed at ?1008.9 on the last day of trading. The high for the day was ?1033.05, while the low was ?1004.95.

April 9, 2024 9:05:00 PM

Natco Pharma on Tuesday said it has received a warning ... The inspection was conducted by USFDA from October 9 to October 18, 2023. "We wish to inform you that the company has received a warning ...

March 12, 2024 3:30:00 AM

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

April 16, 2024 3:30:00 AM

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...